Vemurafenib resistance selects for highly malignant brain and lung-metastasizing melanoma cells-Reference-Cited by-同舟云学术

Vemurafenib resistance selects for highly malignant brain and lung-metastasizing melanoma cells

Published:2015-05 Issue:1 Volume:361 Page:86-96
ISSN:0304-3835
Container-title:Cancer Letters
language:en
Short-container-title:Cancer Letters

Author:

Zubrilov Inna,Sagi-Assif Orit,Izraely Sivan,Meshel Tsipi,Ben-Menahem Shlomit,Ginat Ravit,Pasmanik-Chor Metsada,Nahmias Clara^ORCID,Couraud Pierre-Olivier,Hoon Dave S.B.^ORCID,Witz Isaac P.

Funder

Dr. Miriam and Sheldon G. Adelson Medical Research Foundation

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference69 articles.

1. The Raf/MEK/ERK pathway: new concepts of activation;Peyssonnaux;Biol. Cell,2001

2. Mutations of the BRAF gene in human cancer;Davies;Nature,2002

3. Improved survival with vemurafenib in melanoma with BRAF V600E mutation;Chapman;N. Engl. J. Med,2011

4. Resistance to BRAF-targeted therapy in melanoma;Sullivan;Eur. J. Cancer,2013

5. Systemic treatment for BRAF-mutant melanoma: where do we go next?;Menzies;Lancet Oncol,2014

Cited by 46 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unveiling the Dynamic Interplay between Cancer Stem Cells and the Tumor Microenvironment in Melanoma: Implications for Novel Therapeutic Strategies;Cancers;2024-08-16

2. Chemokines in the tumor microenvironment: implications for lung cancer and immunotherapy;Frontiers in Immunology;2024-07-16

3. Cancer stem cells: advances in knowledge and implications for cancer therapy;Signal Transduction and Targeted Therapy;2024-07-05

4. Single-cell genomics analysis reveals complex genetic interactions in an in vivo model of acquired BRAF inhibitor resistance;NAR Cancer;2024-01-09

5. The origin of brain malignancies at the blood–brain barrier;Cellular and Molecular Life Sciences;2023-09-09